Butler Eyecare Optometrist Medicare: Medicare Enrolled Practice Location: 702 Owens Dr, Lebanon, MO 65536 Phone: 417-839-3721 |
Dr. Michael R Montgomery, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 279 E Elm St, Lebanon, MO 65536 Phone: 417-532-2562 Fax: 417-532-2409 |
Dr. William Grant Iii, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 19595 Houston Rd, Lebanon, MO 65536 Phone: 417-532-9613 |
Family Eyecare Associates 43-1628740 Optometrist Medicare: Medicare Enrolled Practice Location: 279 E Elm, Lebanon, MO 65536 Phone: 417-532-2562 |
Mattax Neu Prater Eye Center, Inc. Optometrist Medicare: Medicare Enrolled Practice Location: 430 N Jefferson Ave, Lebanon, MO 65536 Phone: 417-886-3937 Fax: 417-886-1285 |
Dr. Michael Norman Sommers, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1800 S Jefferson Ave, Lebanon, MO 65536 Phone: 417-533-5466 Fax: 417-533-5480 |
Mercy Clinic-lebanon-eye Specialists Optometrist Medicare: Medicare Enrolled Practice Location: 331 Hospital Dr, Suite E, Lebanon, MO 65536 Phone: 417-533-7540 Fax: 417-533-6550 |
Dr. Cylinda L. Butler, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 331 Hospital Dr, Suite E, Lebanon, MO 65536 Phone: 417-533-6540 Fax: 417-533-6550 |
News Archive
House Budget Committee Chairman Paul Ryan signals that he is "ready to take on health programs" as Capitol Hill continues to struggle with long-term spending concerns. Meanwhile, lawmakers continue talks regarding the current year spending measure still under consideration. A new continuing resolution that would fund government operations until April 8 has emerged.
The University of Texas MD Anderson Cancer Center (Houston, Texas) has purchased two Elekta Versa HD™ linear accelerators. The radiation therapy system, which recently received 510(k) clearance from the U.S. Food and Drug Administration, features the versatility to deliver high-volume conventional techniques, in addition to the most advanced linear-accelerator treatments that require the greatest targeting precision.
Anacor Pharmaceuticals, the University of California San Francisco (UCSF) Sandler Center and the Lindsley F. Kimball Research Institute (LFKRI) of the New York Blood Center (NYBC) today announced the establishment of a research and development collaboration to discover new drug therapies for the treatment of river blindness (onchocerciasis), a parasitic disease that is the second leading cause of infectious blindness worldwide, and is most prevalent in Africa.
The Centers for Medicare and Medicaid Services has released the application for its shared savings program, and Health News Florida reports which of that state's providers will likely throw their hats into the ring.
› Verified 2 days ago